Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3037870
Max Phase: Preclinical
Molecular Formula: C54H79N13O11S2
Molecular Weight: 1150.44
Molecule Type: Unknown
Associated Items:
ID: ALA3037870
Max Phase: Preclinical
Molecular Formula: C54H79N13O11S2
Molecular Weight: 1150.44
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOc1ccc(C[C@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1
Standard InChI: InChI=1S/C54H79N13O11S2/c1-4-32(3)45-51(76)64-39(28-42(55)68)48(73)65-40(52(77)67-25-13-17-41(67)50(75)62-36(16-12-24-59-53(57)58)46(71)60-30-43(56)69)31-79-80-54(22-10-7-11-23-54)29-44(70)61-37(27-34-18-20-35(21-19-34)78-5-2)47(72)63-38(49(74)66-45)26-33-14-8-6-9-15-33/h6,8-9,14-15,18-21,32,36-41,45H,4-5,7,10-13,16-17,22-31H2,1-3H3,(H2,55,68)(H2,56,69)(H,60,71)(H,61,70)(H,62,75)(H,63,72)(H,64,76)(H,65,73)(H,66,74)(H4,57,58,59)/t32-,36-,37+,38-,39-,40-,41-,45-/m0/s1
Standard InChI Key: DEKDTGKNEKWEFW-ZQVAXSIJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1150.44 | Molecular Weight (Monoisotopic): 1149.5463 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Manning M, Przybylski J, Grzonka Z, Nawrocka E, Lammek B, Misicka A, Cheng LL, Chan WY, Wo NC, Sawyer WH.. (1992) Potent V2/V1a vasopressin antagonists with C-terminal ethylenediamine-linked retro-amino acids., 35 (21): [PMID:1433200] [10.1021/jm00099a018] |
Source(1):